UC HEALTH LINE: New Center Offers One-Stop Care for Allergy and Sinus Sufferers
People suffering from chronic sinusitisinflamed mucous membranes in the sinus cavities surrounding the noseoften have to see an otolaryngologist (ear, nose and throat, or ENT, specialist) an allergist and a pulmonologist to treat their symptoms. This can result in multiple doctor appointments and increased time off work.
The respiratory system is one tract, so its common for patients to suffer from nasal and sinus problems as well as lower respiratory conditions such as asthma, says Allen Seiden, MD, an otolaryngologist at UC. They may need to see an allergist, an ENT specialist and a pulmonologist because each one treats different aspects of the respiratory system.
To help expedite diagnosis and treatment, the University of Cincinnati (UC) is opening the first comprehensive respiratory center in the region.
Seiden and UC colleague Lee Zimmer, MD, are partnering with allergists Lawrence Newman, MD, and Steven Sutton, MD, to treat allergy and sinus sufferers in one locationthe University Sinus and Allergy center at University Pointe in West Chester.
Prior to their visit, patients are screened and appointments scheduled with multiple specialists in one location on the same day. They may be evaluated by an otolaryngologist and an allergist during their visit and undergo specialized diagnostic tests, such as nasal endoscopy, allergy testing, bronchoscopy and pulmonary function testing.
The specialists will collaboratively discuss each patients case and develop a comprehensive, multidisciplinary treatment plan.
By working together, we have a much broader perspective on treatment, and we hope this leads to better control for a patients condition, says Seiden.
For more information or to schedule an appointment at University Sinus and
More information on allergies and sinus issues is available at www.netwellness.org, a collaborative health-information Web site run by UC,
Lee Zimmer, MD, specializes in head and neck surgery.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.